CAMP Q4 2022 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+14.7% YoY

Gross Profit

$27M33.7% margin

Operating Income

-$4M-4.6% margin

Net Income

-$5M-6.0% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+8.3%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$568,999

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$389M

Total Liabilities

$370M

Stockholders' Equity

$19M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$69M	+14.7%
Gross Profit	$27M	$28M	-5.0%
Operating Income	-$4M	-$7M	+44.6%
Net Income	-$5M	-$11M	+58.6%

Revenue Segments

Product

$53M68%

Application Subscriptions And Other Services

$26M32%

Geographic Segments

UNITED STATES

$50M64%

E M E A

$15M19%

Latin America

$9M11%

Asia Pacific

$3M4%

All Other

$2M2%